世界のうつ病治療薬市場予測2023-2029:SSRI、SNRI、その他

【英語タイトル】Depression Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23FB2178)・商品コード:MMG23FB2178
・発行会社(調査会社):Market Monitor Global
・発行日:2023年2月
・ページ数:62
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥481,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥625,300見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥721,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のうつ病治療薬市場規模と予測を収録しています。・世界のうつ病治療薬市場:売上、2018年-2023年、2024年-2029年
・世界のうつ病治療薬市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のうつ病治療薬市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「SSRI」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

うつ病治療薬のグローバル主要企業は、Intellipharmaceutics、Pfizer、Eli Lilly、Astrazeneca、Lundbeck、Allergan、GSK、Otsuka Pharmaceutical、Takeda、NHU Group、Shionogi、APOTEX、Kanghong Pharma、HUAHAIなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、うつ病治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のうつ病治療薬市場:タイプ別、2018年-2023年、2024年-2029年
世界のうつ病治療薬市場:タイプ別市場シェア、2022年
・SSRI、SNRI、その他

世界のうつ病治療薬市場:用途別、2018年-2023年、2024年-2029年
世界のうつ病治療薬市場:用途別市場シェア、2022年
・病院、診療所、その他

世界のうつ病治療薬市場:地域・国別、2018年-2023年、2024年-2029年
世界のうつ病治療薬市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるうつ病治療薬のグローバル売上、2018年-2023年
・主要企業におけるうつ病治療薬のグローバル売上シェア、2022年
・主要企業におけるうつ病治療薬のグローバル販売量、2018年-2023年
・主要企業におけるうつ病治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Intellipharmaceutics、Pfizer、Eli Lilly、Astrazeneca、Lundbeck、Allergan、GSK、Otsuka Pharmaceutical、Takeda、NHU Group、Shionogi、APOTEX、Kanghong Pharma、HUAHAI

*************************************************************

・調査・分析レポートの概要
うつ病治療薬市場の定義
市場セグメント
世界のうつ病治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のうつ病治療薬市場規模
世界のうつ病治療薬市場規模:2022年 VS 2029年
世界のうつ病治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのうつ病治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のうつ病治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:SSRI、SNRI、その他
うつ病治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院、診療所、その他
うつ病治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別うつ病治療薬市場規模 2022年と2029年
地域別うつ病治療薬売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Intellipharmaceutics、Pfizer、Eli Lilly、Astrazeneca、Lundbeck、Allergan、GSK、Otsuka Pharmaceutical、Takeda、NHU Group、Shionogi、APOTEX、Kanghong Pharma、HUAHAI

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Depression Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Depression Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Depression Drugs Overall Market Size
2.1 Global Depression Drugs Market Size: 2022 VS 2029
2.2 Global Depression Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Depression Drugs Players in Global Market
3.2 Top Global Depression Drugs Companies Ranked by Revenue
3.3 Global Depression Drugs Revenue by Companies
3.4 Top 3 and Top 5 Depression Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Depression Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Depression Drugs Players in Global Market
3.6.1 List of Global Tier 1 Depression Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Depression Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Depression Drugs Market Size Markets, 2022 & 2029
4.1.2 SSRIs
4.1.3 SNRIs
4.1.4 Others
4.2 By Type – Global Depression Drugs Revenue & Forecasts
4.2.1 By Type – Global Depression Drugs Revenue, 2018-2023
4.2.2 By Type – Global Depression Drugs Revenue, 2024-2029
4.2.3 By Type – Global Depression Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Depression Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application – Global Depression Drugs Revenue & Forecasts
5.2.1 By Application – Global Depression Drugs Revenue, 2018-2023
5.2.2 By Application – Global Depression Drugs Revenue, 2024-2029
5.2.3 By Application – Global Depression Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Depression Drugs Market Size, 2022 & 2029
6.2 By Region – Global Depression Drugs Revenue & Forecasts
6.2.1 By Region – Global Depression Drugs Revenue, 2018-2023
6.2.2 By Region – Global Depression Drugs Revenue, 2024-2029
6.2.3 By Region – Global Depression Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Depression Drugs Revenue, 2018-2029
6.3.2 US Depression Drugs Market Size, 2018-2029
6.3.3 Canada Depression Drugs Market Size, 2018-2029
6.3.4 Mexico Depression Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Depression Drugs Revenue, 2018-2029
6.4.2 Germany Depression Drugs Market Size, 2018-2029
6.4.3 France Depression Drugs Market Size, 2018-2029
6.4.4 U.K. Depression Drugs Market Size, 2018-2029
6.4.5 Italy Depression Drugs Market Size, 2018-2029
6.4.6 Russia Depression Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Depression Drugs Market Size, 2018-2029
6.4.8 Benelux Depression Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Depression Drugs Revenue, 2018-2029
6.5.2 China Depression Drugs Market Size, 2018-2029
6.5.3 Japan Depression Drugs Market Size, 2018-2029
6.5.4 South Korea Depression Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Depression Drugs Market Size, 2018-2029
6.5.6 India Depression Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Depression Drugs Revenue, 2018-2029
6.6.2 Brazil Depression Drugs Market Size, 2018-2029
6.6.3 Argentina Depression Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Depression Drugs Revenue, 2018-2029
6.7.2 Turkey Depression Drugs Market Size, 2018-2029
6.7.3 Israel Depression Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Depression Drugs Market Size, 2018-2029
6.7.5 UAE Depression Drugs Market Size, 2018-2029
7 Depression Drugs Companies Profiles
7.1 Intellipharmaceutics
7.1.1 Intellipharmaceutics Company Summary
7.1.2 Intellipharmaceutics Business Overview
7.1.3 Intellipharmaceutics Depression Drugs Major Product Offerings
7.1.4 Intellipharmaceutics Depression Drugs Revenue in Global Market (2018-2023)
7.1.5 Intellipharmaceutics Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Depression Drugs Major Product Offerings
7.2.4 Pfizer Depression Drugs Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Eli Lilly
7.3.1 Eli Lilly Company Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Depression Drugs Major Product Offerings
7.3.4 Eli Lilly Depression Drugs Revenue in Global Market (2018-2023)
7.3.5 Eli Lilly Key News & Latest Developments
7.4 Astrazeneca
7.4.1 Astrazeneca Company Summary
7.4.2 Astrazeneca Business Overview
7.4.3 Astrazeneca Depression Drugs Major Product Offerings
7.4.4 Astrazeneca Depression Drugs Revenue in Global Market (2018-2023)
7.4.5 Astrazeneca Key News & Latest Developments
7.5 Lundbeck
7.5.1 Lundbeck Company Summary
7.5.2 Lundbeck Business Overview
7.5.3 Lundbeck Depression Drugs Major Product Offerings
7.5.4 Lundbeck Depression Drugs Revenue in Global Market (2018-2023)
7.5.5 Lundbeck Key News & Latest Developments
7.6 Allergan
7.6.1 Allergan Company Summary
7.6.2 Allergan Business Overview
7.6.3 Allergan Depression Drugs Major Product Offerings
7.6.4 Allergan Depression Drugs Revenue in Global Market (2018-2023)
7.6.5 Allergan Key News & Latest Developments
7.7 GSK
7.7.1 GSK Company Summary
7.7.2 GSK Business Overview
7.7.3 GSK Depression Drugs Major Product Offerings
7.7.4 GSK Depression Drugs Revenue in Global Market (2018-2023)
7.7.5 GSK Key News & Latest Developments
7.8 Otsuka Pharmaceutical
7.8.1 Otsuka Pharmaceutical Company Summary
7.8.2 Otsuka Pharmaceutical Business Overview
7.8.3 Otsuka Pharmaceutical Depression Drugs Major Product Offerings
7.8.4 Otsuka Pharmaceutical Depression Drugs Revenue in Global Market (2018-2023)
7.8.5 Otsuka Pharmaceutical Key News & Latest Developments
7.9 Takeda
7.9.1 Takeda Company Summary
7.9.2 Takeda Business Overview
7.9.3 Takeda Depression Drugs Major Product Offerings
7.9.4 Takeda Depression Drugs Revenue in Global Market (2018-2023)
7.9.5 Takeda Key News & Latest Developments
7.10 NHU Group
7.10.1 NHU Group Company Summary
7.10.2 NHU Group Business Overview
7.10.3 NHU Group Depression Drugs Major Product Offerings
7.10.4 NHU Group Depression Drugs Revenue in Global Market (2018-2023)
7.10.5 NHU Group Key News & Latest Developments
7.11 Shionogi
7.11.1 Shionogi Company Summary
7.11.2 Shionogi Business Overview
7.11.3 Shionogi Depression Drugs Major Product Offerings
7.11.4 Shionogi Depression Drugs Revenue in Global Market (2018-2023)
7.11.5 Shionogi Key News & Latest Developments
7.12 APOTEX
7.12.1 APOTEX Company Summary
7.12.2 APOTEX Business Overview
7.12.3 APOTEX Depression Drugs Major Product Offerings
7.12.4 APOTEX Depression Drugs Revenue in Global Market (2018-2023)
7.12.5 APOTEX Key News & Latest Developments
7.13 Kanghong Pharma
7.13.1 Kanghong Pharma Company Summary
7.13.2 Kanghong Pharma Business Overview
7.13.3 Kanghong Pharma Depression Drugs Major Product Offerings
7.13.4 Kanghong Pharma Depression Drugs Revenue in Global Market (2018-2023)
7.13.5 Kanghong Pharma Key News & Latest Developments
7.14 HUAHAI
7.14.1 HUAHAI Company Summary
7.14.2 HUAHAI Business Overview
7.14.3 HUAHAI Depression Drugs Major Product Offerings
7.14.4 HUAHAI Depression Drugs Revenue in Global Market (2018-2023)
7.14.5 HUAHAI Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Depression Drugs Market Opportunities & Trends in Global Market
Table 2. Depression Drugs Market Drivers in Global Market
Table 3. Depression Drugs Market Restraints in Global Market
Table 4. Key Players of Depression Drugs in Global Market
Table 5. Top Depression Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Depression Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Depression Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Depression Drugs Product Type
Table 9. List of Global Tier 1 Depression Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Depression Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Depression Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Depression Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Depression Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Depression Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Depression Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Depression Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Depression Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Depression Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Depression Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Depression Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Depression Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Depression Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Depression Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Depression Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Depression Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Depression Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Depression Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Depression Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Depression Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Intellipharmaceutics Company Summary
Table 31. Intellipharmaceutics Depression Drugs Product Offerings
Table 32. Intellipharmaceutics Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Intellipharmaceutics Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Depression Drugs Product Offerings
Table 36. Pfizer Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Eli Lilly Company Summary
Table 39. Eli Lilly Depression Drugs Product Offerings
Table 40. Eli Lilly Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Eli Lilly Key News & Latest Developments
Table 42. Astrazeneca Company Summary
Table 43. Astrazeneca Depression Drugs Product Offerings
Table 44. Astrazeneca Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Astrazeneca Key News & Latest Developments
Table 46. Lundbeck Company Summary
Table 47. Lundbeck Depression Drugs Product Offerings
Table 48. Lundbeck Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Lundbeck Key News & Latest Developments
Table 50. Allergan Company Summary
Table 51. Allergan Depression Drugs Product Offerings
Table 52. Allergan Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Allergan Key News & Latest Developments
Table 54. GSK Company Summary
Table 55. GSK Depression Drugs Product Offerings
Table 56. GSK Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. GSK Key News & Latest Developments
Table 58. Otsuka Pharmaceutical Company Summary
Table 59. Otsuka Pharmaceutical Depression Drugs Product Offerings
Table 60. Otsuka Pharmaceutical Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Otsuka Pharmaceutical Key News & Latest Developments
Table 62. Takeda Company Summary
Table 63. Takeda Depression Drugs Product Offerings
Table 64. Takeda Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Takeda Key News & Latest Developments
Table 66. NHU Group Company Summary
Table 67. NHU Group Depression Drugs Product Offerings
Table 68. NHU Group Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. NHU Group Key News & Latest Developments
Table 70. Shionogi Company Summary
Table 71. Shionogi Depression Drugs Product Offerings
Table 72. Shionogi Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Shionogi Key News & Latest Developments
Table 74. APOTEX Company Summary
Table 75. APOTEX Depression Drugs Product Offerings
Table 76. APOTEX Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. APOTEX Key News & Latest Developments
Table 78. Kanghong Pharma Company Summary
Table 79. Kanghong Pharma Depression Drugs Product Offerings
Table 80. Kanghong Pharma Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Kanghong Pharma Key News & Latest Developments
Table 82. HUAHAI Company Summary
Table 83. HUAHAI Depression Drugs Product Offerings
Table 84. HUAHAI Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. HUAHAI Key News & Latest Developments
List of Figures
Figure 1. Depression Drugs Segment by Type in 2022
Figure 2. Depression Drugs Segment by Application in 2022
Figure 3. Global Depression Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Depression Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Depression Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Depression Drugs Revenue in 2022
Figure 8. By Type - Global Depression Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Depression Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Depression Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Depression Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Depression Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Depression Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Depression Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Depression Drugs Revenue Market Share, 2018-2029
Figure 16. US Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Depression Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Depression Drugs Revenue Market Share, 2018-2029
Figure 28. China Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Depression Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Depression Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Intellipharmaceutics Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Eli Lilly Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Astrazeneca Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Lundbeck Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Allergan Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. GSK Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Otsuka Pharmaceutical Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Takeda Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. NHU Group Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Shionogi Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. APOTEX Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Kanghong Pharma Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. HUAHAI Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



★調査レポート[世界のうつ病治療薬市場予測2023-2029:SSRI、SNRI、その他] (コード:MMG23FB2178)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のうつ病治療薬市場予測2023-2029:SSRI、SNRI、その他]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆